CytoFLEX LX Cell Analyzer

CytoFLEX LX 细胞分析仪

基本信息

  • 批准号:
    10177735
  • 负责人:
  • 金额:
    $ 29.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-20 至 2022-09-19
  • 项目状态:
    已结题

项目摘要

Summary UCSC proposes to purchase a Beckmann and Coulter CytoFLEX LX cell analyzer with 6 lasers (UV, violet, blue, yellow-green, red, far red) and a plate-loader accessory. Our current, aging, 3-laser LSR II flow cytometer must be replaced, because maintenance for that model will be discontinued in 2021. Additionally, most users require a modern cell analyzer that offers more colors for cell analysis, as well as the small sample volume and high throughput afforded by the plate-loader. The CytoFLEX LX cell analyzer will allow users to interrogate individual cells that are labeled with up to 20 different fluorophores at once. The plate loader will streamline the analysis of multiple samples and reduce the required sample volume significantly from 4-mL sample tubes to wells in a 96-well plate. The small sample volume is particularly important for our many stem cell researchers who often work with very rare, primary cells. Major users will rely on this new instrument to advance important biomedical issues in their NIH-funded research grants, including investigations of: a) age-induced changes in blood stem cells and implications for geriatric ailments, b) the role and regulation of a novel, developmentally restricted hematopoietic stem cell, c) the role of the long non-coding RNA GAPLINC in septic shock and inflammation, and d) the mechanisms governing cell fate acquisition and alveologenesis in the mammary gland. Minor users will address diverse biomedical problems, such as establishing the details of bacterial pathogen infections, the regulation of stem cell differentiation in human development, cell membrane permeability for drugs, and peptides, and the functional characterization of natural products for drug development. The proposed instrument will be housed in UCSC’s Cytometry Core facility, which was established in 2007. Instrument supervision, training, maintenance scheduling, and recharge accounting for use of the proposed instrument will be assured by our Cytometry Core Facility manager, whose salary is guaranteed by the UCSC.
总结 UCSC建议购买Beckmann和Coulter CytoFLEX LX细胞分析仪,配有6个激光器(UV,紫光, 蓝色、黄绿色、红色、远红色)和印版装载器附件。我们目前的老化3激光LSR II流式细胞仪 必须更换,因为该型号的维护将于2021年停止。此外,大多数用户 需要一个现代化的细胞分析仪,为细胞分析提供更多的颜色,以及小的样品体积, 装版机提供高吞吐量。CytoFLEX LX细胞分析仪将允许用户询问 单个细胞同时被多达20种不同的荧光团标记。板装载机将简化 分析多个样品,并将所需的样品体积从4 mL样品管显著减少到 96孔板中的威尔斯孔。小样本量对于我们众多的干细胞研究者来说尤为重要 who often经常work with very rare罕见,primary原代cells细胞. 主要用户将依靠这一新工具来推进其NIH资助的重要生物医学问题。 研究赠款,包括调查:a)年龄引起的造血干细胞变化及其对 老年病,B)一种新的发育受限的造血干细胞的作用和调节,c) 长链非编码RNA GAPLINC在感染性休克和炎症中的作用,以及d)其机制 控制乳腺中的细胞命运获得和肺泡发生。少数用户将解决各种 生物医学问题,如建立细菌病原体感染的细节,干细胞的调节, 人类发育中的细胞分化,药物和肽的细胞膜渗透性,以及 用于药物开发的天然产物的功能表征。 拟议的仪器将被安置在UCSC的细胞计数核心设施,这是建立在 2007.仪器监督、培训、维护计划和使用的再充电核算 建议的仪器将由我们的细胞计数核心设施经理保证,其工资由 UCSC。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CAMILLA FORSBERG其他文献

CAMILLA FORSBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CAMILLA FORSBERG', 18)}}的其他基金

A postdoctoral training program for impactful careers in stem cell biology
干细胞生物学领域有影响力的职业博士后培训计划
  • 批准号:
    10410891
  • 财政年份:
    2022
  • 资助金额:
    $ 29.68万
  • 项目类别:
IRACDA at UCSC and CSUMB
UCSC 和 CSUMB 的 IRACDA
  • 批准号:
    10676248
  • 财政年份:
    2020
  • 资助金额:
    $ 29.68万
  • 项目类别:
IRACDA at UCSC and CSUMB
UCSC 和 CSUMB 的 IRACDA
  • 批准号:
    10460280
  • 财政年份:
    2020
  • 资助金额:
    $ 29.68万
  • 项目类别:
IRACDA at UCSC and CSUMB
UCSC 和 CSUMB 的 IRACDA
  • 批准号:
    10056092
  • 财政年份:
    2020
  • 资助金额:
    $ 29.68万
  • 项目类别:
IRACDA at UCSC and CSUMB
UCSC 和 CSUMB 的 IRACDA
  • 批准号:
    10239236
  • 财政年份:
    2020
  • 资助金额:
    $ 29.68万
  • 项目类别:
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells
定义造血干细胞衰老特异性血小板规格的原因和后果
  • 批准号:
    10399429
  • 财政年份:
    2019
  • 资助金额:
    $ 29.68万
  • 项目类别:
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells
定义造血干细胞衰老特异性血小板规格的原因和后果
  • 批准号:
    10621901
  • 财政年份:
    2019
  • 资助金额:
    $ 29.68万
  • 项目类别:
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells
定义造血干细胞衰老特异性血小板规格的原因和后果
  • 批准号:
    10100559
  • 财政年份:
    2019
  • 资助金额:
    $ 29.68万
  • 项目类别:
Defining the cause and consequence of aging-specific platelet specification from hematopoietic stem cells
定义造血干细胞衰老特异性血小板规格的原因和后果
  • 批准号:
    10017134
  • 财政年份:
    2019
  • 资助金额:
    $ 29.68万
  • 项目类别:
Role and Regulation of a Novel, Developmentally Restricted Hematopoietic Stem Cell
新型发育受限造血干细胞的作用和调节
  • 批准号:
    10407592
  • 财政年份:
    2013
  • 资助金额:
    $ 29.68万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.68万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了